TRHC TABULA RASA HEALTHCARE

Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences

Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences

MOORESTOWN, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chairman and CEO, Calvin H. Knowlton, Ph.D. and Chief Financial Officer, Brian W. Adams, will participate in upcoming investor conferences.

Mr. Adams is scheduled to present at the Jefferies 2019 Healthcare Conference in New York, NY on Wednesday, June 5, 2019 at 4:00 pm ET.

Dr. Knowlton and Mr. Adams are scheduled to present at the William Blair 39th Annual Growth Stock Conference in Chicago, IL on Thursday, June 6, 2019 at 2:40 pm CT. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at ir.trhc.com. The archived webcast and presentation materials will also be available for 90 days at the same URL.

Mr. Adams is scheduled to present at the Stifel 2019 Cross Sector Insight Conference in Boston, MA on Monday, June 10, 2019 at 2:25 pm ET.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.  Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit: .

Contact:

Investors

Bob East or Asher Dewhurst

Westwicke Partners

443-213-0500

 

Media

Dianne Semingson

 

T: 215-870-0829

EN
22/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TABULA RASA HEALTHCARE

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 27, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 25, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Tabula Rasa Healthcare Inc: 3 directors

A director at Tabula Rasa Healthcare Inc bought 2,000 shares at 5.630USD and the significance rating of the trade was 34/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch